FDA Inspection 1205193 — OrganaBio LLC
The FDA completed an inspection of OrganaBio LLC on May 4, 2023 in South Miami, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 4, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- South Miami, FL (United States)